HER2 + BREAST CANCER

Clinical trials for HER2 + BREAST CANCER explained in plain language.

Never miss a new study

Get alerted when new HER2 + BREAST CANCER trials appear

Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 10 Not yet recruiting 3 Not yet finished but already full! 2 Terminated 1

Heart-Saving combo tested for breast cancer patients

Disease control Terminated

This pilot study aimed to see if giving heart medications (carvedilol and empagliflozin) before or during HER2-targeted breast cancer treatment could prevent heart damage. Only 7 of the planned 20-40 participants were enrolled before the study was stopped early. The goal was to t…

Matched conditions: HER2 + BREAST CANCER

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated May 15, 2026 11:55 UTC

HER2 + BREAST CANCER

Get alerted when new HER2 + BREAST CANCER trials appear

Heart-Saving combo tested for breast cancer patients